These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of immunostimulating agents on viral infections. Zerial A; Werner GH Acta Microbiol Acad Sci Hung; 1981; 28(3):325-37. PubMed ID: 6171144 [No Abstract] [Full Text] [Related]
8. [Treatment of the primary immunodeficiency diseases. Present state of the art (author's transl)]. Fontán G; García Rodríguez MC; Ojeda JA An Esp Pediatr; 1981 Dec; 15(6):563-72. PubMed ID: 6175263 [No Abstract] [Full Text] [Related]
9. Immunostimulation: synthetic and biological modulators of immunity. Fudenberg HH; Whitten HD Annu Rev Pharmacol Toxicol; 1984; 24():147-74. PubMed ID: 6203479 [No Abstract] [Full Text] [Related]
10. Biological response modifiers and their promise in clinical medicine. Attallah AM; Yeatman TJ; Johnson RP; Petricciani JC Pharmacol Ther; 1982; 19(3):435-54. PubMed ID: 6201933 [No Abstract] [Full Text] [Related]
11. Thymic humoral factor (THF) therapy in a patient with Di-George syndrome. Ersoy F; Sanal O; Yeğin O; Berkel AI; Cağlar M Turk J Pediatr; 1982; 23(2):115-20. PubMed ID: 7201177 [No Abstract] [Full Text] [Related]
12. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome. Hamilton G; Zöch G; Rath T; Meissl G Prog Clin Biol Res; 1989; 308():995-9. PubMed ID: 2528748 [No Abstract] [Full Text] [Related]
13. [Clinical value of immunotherapy for gynecological cancer by BRM (biological response modifier)]. Akiya K; Negishi Y Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):1025-9. PubMed ID: 2410519 [No Abstract] [Full Text] [Related]
14. [Immunomodulating treatment of patients with HIV infection]. Skotnicki AB; Kornaszewski W Przegl Dermatol; 1989; 76(4):285-91. PubMed ID: 2483589 [No Abstract] [Full Text] [Related]
15. [Treatment of dysfunction of cellular immunity and the prospect for future]. Igarashi T; Azuma I; Yamamura Y Nihon Rinsho; 1978; 36(5):1011-7. PubMed ID: 353324 [No Abstract] [Full Text] [Related]
16. Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants. Mathe G Comp Immunol Microbiol Infect Dis; 1980; 3(4):407-32. PubMed ID: 6451350 [No Abstract] [Full Text] [Related]
17. Thymic hormone in the treatment of cancer. Dardeene M; Bach JF Prog Clin Biol Res; 1989; 288():363-82. PubMed ID: 2654955 [No Abstract] [Full Text] [Related]
18. Thymopentin in dermatology. Haneke E Curr Probl Dermatol; 1989; 18():283-9. PubMed ID: 2663371 [No Abstract] [Full Text] [Related]